News
12/11/2018
Positive results reported in study evaluating AHSCT using the BEAM conditioning regimen in patients with active, treatment-refractory MS
11/29/2018
New FDA warning about risk of stroke and blood vessel wall tears with Lemtrada (alemtuzumab)
10/23/2018
Pregnancy rates increasing in women with MS in the United States
9/13/2018
Publication of the clinical trial testing Gilenya (fingolimd) for pediatric MS
8/30/2018
Phase 2 study shows a positive effect of ibudilast on brain atrophy in progressive MS but some safety signals
7/30/2018